Otto Krayer papers

Otto Krayer (1899-1982), M.D., 1926, University of Freiburg, Germany, was a pharmacologist, professor, and researcher. Krayer was an international leader in the field of pharmacology and Head of the Department of Pharmacology at Harvard Medical School, Boston, Massachusetts, for twenty-eight years. In 1933, Krayer refused an appointment to an academic chair at the University of Dusseldorf, Germany after the removal of the Jewish incumbent by Nazi government officials in Germany. For this, Krayer was banned from German academic, library, and scientific facilities, prompting relocations to England, Lebanon, and eventually the United States of America. Krayer’s primary research focus during his tenure at Harvard Medical School was cardiac pharmacology and veratrum alkaloids.

Otto Herman Krayer was born in Kondringen, Germany, on October 22, 1899, the son of Frieda Wolfsperger and Hermann Krayer. A 1939 passenger list lists Krayer’s race as German. Growing up, Krayer helped his parents run an inn and operate the family farm. During World War I, he was drafted into the German Army in 1917, at age eighteen. Krayer saw frontline infantry combat from April to October 1918 and was wounded in battle before the 1918 armistice. During his recovery, Krayer completed his university entrance requirements and in 1919 entered the University of Freiburg, Germany to study medicine. Krayer earned his M.D. in 1926.

After receiving his M.D., Krayer joined the Department of Pharmacology at Freiburg, working under pharmacologist Paul Trendelenburg (1884-1931). In 1927, Trendelenburg moved to the University of Berlin, Germany to become the head of the pharmacology department and Krayer followed. After Trendelenburg’s death in 1931, Krayer was made acting head of the department and, in 1932, was appointed Professor Extraordinarius of Pharmacology and Toxicology. In the spring of 1933, Krayer was offered a departmental chair position at the University of Dusseldorf. Krayer declined, as the Jewish incumbent, Philipp Ellinger, had been removed from the chair on racial grounds by the Nazi government. As a result, the Prussian Minister for Science, Art and National Education suspended Krayer from his academic positions and banned him from German academic, library, and scientific facilities. In October 1933, Krayer was reinstated to the University of Berlin and had his academic privileges restored, but, having secured a Rockefeller Fellowship, left Germany at the end of 1933 for University College, London.

After his fellowship ended in the fall of 1934, Krayer moved to American University Beirut as Visiting Professor and Head of the Department of Pharmacology. In 1936, Krayer was American University’s representative to Harvard University’s Tercentenary Celebration. That fall, he stayed on as a visiting lecturer in pharmacology at Harvard Medical School. Encouraged by Walter B. Cannon (1871-1945), Krayer returned to Harvard in 1937 and was appointed Associate Professor of Pharmacology. In 1939, Krayer was appointed Associate Professor of Comparative Pharmacology and Head of the Department of Pharmacology, a position he held until a Harvard-mandated retirement in 1966. Krayer would go on to be appointed Professor of Pharmacology (1951), Charles Wilder Professor of Pharmacology (1954), and Gustavus Adolphus Pfeiffer Professor of Pharmacology (1964, Emeritus 1966).

As Head of the Harvard Medical School's Pharmacology Department, Krayer was known for emphasizing collaboration among his staff and maintaining a balance between the Department’s teaching and research functions. He also recognized the importance of incorporating other fields, namely biochemistry, physiology, and psychology, into pharmacological research, in order to study the full range of the effects of pharmaceuticals. Krayer’s primary research focus during his tenure was cardiac pharmacology and veratrum alkaloids, and he was noted for his skill in using the Starling heart-lung preparation. Additionally, influenced by B. F. Skinner (1904-1990), Krayer and department member Peter B. Dews (born 1922) explored the behavioral effects of drugs and helped to legitimize it as field of study within pharmacology. In 1938, Krayer, frustrated in his dealings with the administration at the medical school, accepted a position at Peiping Union Medical College, China, but ultimately remained at Harvard, in part due a petition signed by his students asking the medical school administration to retain him. Though Krayer had a difficult relationship with Dean C. Sidney Burwell (1893-1967), he formed a productive relationship with his successor, Dean George Packer Berry (1898-1986).

During World War II, the United States government classified Krayer as an “enemy alien,” and Krayer’s travel was restricted to a twenty-five mile radius around Boston. During the immediate post-war period, Krayer joined Unitarian Service Committee-sponsored medical missions to Czechoslovakia (1946) and Germany (1948). He was also a supporter of the Committee for Aid to German and Austrian Scholars, serving as secretary-treasurer of a fundraising committee based at Harvard Medical School. Krayer was highly involved with the American Society for Pharmacology and Experimental Therapeutics, becoming a member in 1938 and serving as president (1957-1958) and as chairman of the Board of Publications Trustees (1960-1962). He served as an editor for the Society’s journal, Pharmacological Reviews (1948-1959), including editor-in-chief (1953-1959). Krayer also served as an Associate Editor for the German publication Ergebnisse der Physiologie (1933-1935, 1939-1976).

During his career, Krayer received the following awards and honors: the inaugural Torald Sollmann Award of the American Society for Pharmacology and Experimental Therapeutics (1961); Schmiedeberg Plakette of the German Pharmacological Society (1964); Otto Krayer Lectureship at Harvard Medical School (established 1966); Research Achievement Award, American Heart Association (1969); Otto Krayer Award in Pharmacology, American Society for Pharmacology and Experimental Therapeutics (established 1985). Additionally, the Otto Krayer Professorship of Pharmacology was established at Harvard Medical School in 1981. Krayer received honorary degrees from Harvard University, the University of Freiburg, the University of Gottingen, Germany, and the Technical University of Munich, Germany.

Krayer married physician Erna Ruth Phillip (1900-1994), his long-time assistant, in 1939. The two first met while Krayer was studying at Freiburg in the early 1920s. Erna was also a victim of antisemitic Nazi policies, having been dismissed from a Berlin hospital position for being Jewish. She assisted Otto in completing the book began by his mentor Paul Trendelenburg, Die Hormone, after Otto had been banned from German libraries. Erna moved with him to Beirut, Lebanon as his literary assistant, and then to Boston as well. The couple had no children. After retiring, Krayer moved to Tucson, Arizona in 1972, serving as Visiting Professor in the Department of Pharmacology, College of Medicine, University of Arizona, Tucson (1972-1980), and spent his summers in Germany as a Visiting Professor, Department of Pharmacology, Technical University of Munich (1972-1980). Krayer died in 1982 of prostate cancer.